Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease

Luke Whiley, Katie Chappell, Ellie D'Hondt, Matthew Lewis, Beatriz Jimenez, Stuart Snowden, Hilkka Soininen, Iwona Kloszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, Jonathan Swann, Abdul Hye, Simon Lovestone, Cristina Legido-Quigley, Elaine Holmes

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number20
JournalAlzheimer's Research and Therapy
Volume13
DOIs
Publication statusPublished - 9 Jan 2021

Cite this